<SEC-DOCUMENT>0001812865-20-000027.txt : 20200904
<SEC-HEADER>0001812865-20-000027.hdr.sgml : 20200904
<ACCEPTANCE-DATETIME>20200904184120
ACCESSION NUMBER:		0001812865-20-000027
CONFORMED SUBMISSION TYPE:	4/A
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20200902
FILED AS OF DATE:		20200904
DATE AS OF CHANGE:		20200904

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			RAMALINGAM AJIT
		CENTRAL INDEX KEY:			0001807891

	FILING VALUES:
		FORM TYPE:		4/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-07928
		FILM NUMBER:		201162699

	MAIL ADDRESS:	
		STREET 1:		C/O BIO-RAD LABORATORIES, INC.
		STREET 2:		1000 ALFRED NOBEL DRIVE
		CITY:			HERCULES
		STATE:			CA
		ZIP:			94547

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIO-RAD LABORATORIES, INC.
		CENTRAL INDEX KEY:			0000012208
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				941381833
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1000 ALFRED NOBEL DRIVE
		CITY:			HERCULES
		STATE:			CA
		ZIP:			94547
		BUSINESS PHONE:		5107247000

	MAIL ADDRESS:	
		STREET 1:		1000 ALFRED NOBEL DRIVE
		CITY:			HERCULES
		STATE:			CA
		ZIP:			94547

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BIO RAD LABORATORIES INC
		DATE OF NAME CHANGE:	19920703
</SEC-HEADER>
<DOCUMENT>
<TYPE>4/A
<SEQUENCE>1
<FILENAME>edgar.xml
<DESCRIPTION>PRIMARY DOCUMENT
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4/A</documentType>

    <periodOfReport>2020-09-02</periodOfReport>

    <dateOfOriginalSubmission>2020-09-04</dateOfOriginalSubmission>

    <issuer>
        <issuerCik>0000012208</issuerCik>
        <issuerName>BIO-RAD LABORATORIES, INC.</issuerName>
        <issuerTradingSymbol>BIO, BIOB</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001807891</rptOwnerCik>
            <rptOwnerName>RAMALINGAM AJIT</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O BIO-RAD LABORATORIES, INC.</rptOwnerStreet1>
            <rptOwnerStreet2>1000 ALFRED NOBEL DRIVE</rptOwnerStreet2>
            <rptOwnerCity>HERCULES</rptOwnerCity>
            <rptOwnerState>CA</rptOwnerState>
            <rptOwnerZipCode>94547</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>1</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle>SVP, Chief Accounting Officer</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable></nonDerivativeTable>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>Restricted Stock Units</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>0</value>
                <footnoteId id="F1"/>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2020-09-02</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>963</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <footnoteId id="F2"/>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F2"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Bio-Rad A Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>963</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>963</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.</footnote>
        <footnote id="F2">The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.</footnote>
    </footnotes>

    <remarks>This Amendment is being filed to attach the Power of Attorney that was inadvertently omitted on the initial filing of this Form 4.</remarks>

    <ownerSignature>
        <signatureName>/s/ Ronald W. Hutton, attorney-in-fact</signatureName>
        <signatureDate>2020-09-04</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24
<SEQUENCE>2
<FILENAME>attachment_1.htm
<DESCRIPTION>THIS AMENDMENT IS BEING FILED TO ATTACH THE POWER OF ATTORNEY THAT WAS INADVERTENTLY OMITTED ON THE INITIAL FILING OF THIS FORM 4.
<TEXT>
<html><body><pre>POWER OF ATTORNEY



Know all by these presents, that the undersigned hereby constitutes and appoints each of Ronald

W. Hutton and Timothy S. Ernst, or either of them acting singly, and with full power of

substitution, the undersigned&#39;s true and lawful attorney-in-fact to:



(1) execute for and on behalf of the undersigned, in the undersigned&#39;s capacity as an officer

and/or director of Bio-Rad Laboratories, Inc. (the &quot;Company&quot;), Forms 3, 4, 5 and 144 in

accordance with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder;



(2) do and perform any and all acts for and on behalf of the undersigned which may be

necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and execute

any amendment or amendments thereto, and timely file such form with the United States

Securities and Exchange Commission and any stock exchange or similar authority; and



(3) take any other action of any type whatsoever in connection with the foregoing which, in the

opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required

by, the undersigned, it being understood that the documents executed by such attorney-in-fact on

behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall

contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact&#39;s

discretion.



The undersigned hereby grants to each such attorney-in-fact full power and authority to do and

perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the

exercise of any of the rights and powers herein granted, as fully to all intents and purposes as

the undersigned might or could do if personally present, with full power of substitution or

revocation, hereby ratifying and confirming all that such attorney-in-fact, or such

attorney-in-fact&#39;s substitute or substitutes, shall lawfully do or cause to be done by virtue of this

power of attorney and the rights and powers herein granted. The undersigned acknowledges

that the foregoing attorneys-in-fact, in serving in such capacity at the request of the

undersigned, are not assuming, nor is the Company assuming, any of the undersigned&#39;s

responsibilities to comply with Section 16 of the Securities Exchange Act of 1934.



This Power of Attorney shall remain in full force and effect until the undersigned is no longer

required to file Forms 3, 4, 5 and 144 with respect to the undersigned&#39;s holdings of and

transactions in securities issued by the Company, unless earlier revoked by the undersigned in a

signed writing delivered to the foregoing attorneys-in-fact.



IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as

of this 27th day of August, 2020.



/s/ Ajit Ramalingam

</pre></body></html>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
